IMPROVED DETECTION OF FAMILIAL HYPERCHOLESTEROLEMIA BY DETERMINING LOW-DENSITY-LIPOPROTEIN RECEPTOR EXPRESSION IN MITOGEN-INDUCED PROLIFERATING LYMPHOCYTES
Pc. Chan et al., IMPROVED DETECTION OF FAMILIAL HYPERCHOLESTEROLEMIA BY DETERMINING LOW-DENSITY-LIPOPROTEIN RECEPTOR EXPRESSION IN MITOGEN-INDUCED PROLIFERATING LYMPHOCYTES, Journal of lipid research, 39(11), 1998, pp. 2261-2270
In view of the presence of some 190 mutations in the low density lipop
rotein receptor (LDLR) gene and a lack of simple detection methods, we
have developed an improved assay system for detecting familial hyperc
holesterolemia (FH) using mitogen-induced proliferating lymphocytes, F
reshly isolated mononuclear cells were cultured for 3 days in RPMI 164
0 supplemented with 10% human lipoprotein-deficient serum (LPDS) and 1
% phytohemagglutinin (PHA), LDLR expression was measured by how cytome
try using a monoclonal anti-LDL-R antibody or DiI-LDL, Mitogenic respo
nses were monitored by cell size (FSC), interleukin-2 receptor (IL2-R)
expression, and stimulation index (SI), The LDL-R expression in PHA-s
timulated lymphocytes was significantly higher than lymphocytes or mon
ocytes cultured without PHA (15.2- and 3.6-fold, respectively). The gr
adation of the LDL-R expression was highly correlated to FSC, IL2-R ex
pression, and SI (r > 0.9 in each case). However, no difference in FSC
, IL2-R expression, or SI existed between 30 clinically diagnosed FH a
nd 42 normolipemic control subjects. The significantly lower LDL-R exp
ression in the FH group (45.2 +/- 15.3% versus 100 +/- 14.1%; unpaired
t test, P < 0.0001) indicated the presence of genetic defects. Normoc
holesterolemic first degree relatives and non-FH hypercholesterolemic
subjects demonstrated normal LDL-R expression as did the controls. The
assay carries an efficiency of 97% and both sensitivity and specifici
ty of 98.5%. Measurement of low density lipoprotein receptor expressio
n in phytohemagglutinin- and lipoprotein-deficient serum-stimulated ly
mphocytes offers a simple method for detecting familial hypercholester
olemia with improved sensitivity.